Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.
about
Nicotine replacement therapy for smoking cessationInterventions for preventing weight gain after smoking cessationNicotine replacement therapy for smoking cessationMolecular genetics of successful smoking cessation: convergent genome-wide association study resultsA review of pharmacogenetic studies of substance-related disordersADHD and smoking: from genes to brain to behaviorConverging findings from linkage and association analyses on susceptibility genes for smoking and other addictions.The significant association of Taq1A genotypes in DRD2/ANKK1 with smoking cessation in a large-scale meta-analysis of Caucasian populationsCommon and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation.Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers.Effects of Acute Nicotine Abstinence on Cue-elicited Ventral Striatum/Nucleus Accumbens Activation in Female Cigarette Smokers: A Functional Magnetic Resonance Imaging Study.Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses.Association of the DRD2 gene Taq1A polymorphism and smoking behavior: a meta-analysis and new data.Sex heterogeneity in pharmacogenetic smoking cessation clinical trialsNeurotransmission-related genetic polymorphisms, negative affectivity traits, and gender predict tobacco abstinence symptoms across 44 days with and without nicotine patch.Sex differences in TTC12/ANKK1 haplotype associations with daily tobacco smoking in Black and White Americans.Are adolescents with ADHD interested in genetic testing for nicotine addiction susceptibility?Pharmacogenetics of nicotine addiction: role of dopaminePharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trialsCHRNA3 rs1051730 genotype and short-term smoking cessationGenetic epidemiology and primary care.Biomarkers of Response to Smoking Cessation Pharmacotherapies: Progress to Date.Biomarkers to optimize the treatment of nicotine dependence.Association of COMT Val108/158Met genotype with smoking cessation in a nicotine replacement therapy randomized trialThe serotonin transporter 5-HTTLPR polymorphism and treatment response to nicotine patch: follow-up of a randomized controlled trial.Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessationPharmacogenetics and nicotine addiction treatment.Genetics and smoking cessation improving outcomes in smokers at riskGenetics of nicotine dependence and pharmacotherapy.A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessationDrugs and genotypes: how pharmacogenetic information could improve smoking cessation treatment.Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch.Current and emerging pharmacotherapies for treating tobacco dependence.Overview of the pharmacogenomics of cigarette smoking.The influence of genetics on nicotine dependence and the role of pharmacogenetics in treating the smoking habit.The CHRNA3 rs578776 Variant is Associated with an Intrinsic Reward Sensitivity Deficit in Smokers.Genetic variation in the dopamine pathway and smoking cessation.DRD2-related TaqIA polymorphism modulates motivation to smoke.Pharmacogenetics of alcohol, nicotine and drug addiction treatments.Genetics of dopamine receptors and drug addiction.
P2860
Q24202991-B2EBA759-3504-4F5E-A628-02661E0451D5Q24203883-ADA34F8A-64C5-4F6E-A785-C805A4F8C577Q24242851-6326195A-CB02-4B5A-B1E3-AF65A0537A69Q24653819-99E16FC2-DB82-4628-851A-848659E9D02DQ27312296-D3B3DEB7-D6E5-42F7-ACC5-A62179CC6739Q28300210-3937589A-B0C5-4039-9143-32B5B56237D6Q30276828-4BFC0CCF-0242-4740-984E-F8CFD8D98697Q30277983-34E3B270-8C81-4A70-B857-C16AFE940D58Q30435362-A15CDD43-3E8D-4630-BEC4-E39F60D5DCD2Q30486679-C970DD21-CA93-4678-995B-750C5757065FQ30494499-57283476-B102-49AA-A69C-C990805946E9Q31159653-4BB501AD-E870-4E41-83F3-A76EB6A2D975Q33412991-11898211-3C6F-41A7-AEEA-FF0E3508FC47Q33605769-6AA5CBD3-7F07-4ED3-824D-D8B965D72A63Q33609822-A31FC29F-ED6E-4B20-8B98-4AA852495201Q33671613-918A6DDA-E58A-4B3D-AA82-069974EC1624Q33859099-655B5982-1268-46B0-A3A0-45A969A8717EQ34132214-BB06F51C-4CA6-4E53-B17A-B9757BC4818BQ35022995-07DDE494-4051-4FE6-8243-566B31F4DD6AQ35231050-5274B569-108D-448B-A407-DE39D691EB6CQ35688722-D0A7EA4F-B595-446C-B634-9B27E6E0F876Q35751986-A3257B22-C0BA-42AC-9C21-C94D60DD7E9EQ35773685-A809CCED-BC37-40D9-90DB-535367383534Q36076504-39FE14F5-A63E-4F83-BF3E-31AED8BAB324Q36076508-7BEA88F7-AB69-464B-8FFE-66905028F1EDQ36087706-4F05191F-1705-4A72-93DD-57A538A01C3DQ36192658-E67FEA30-77D3-4011-B135-F38D27559937Q36319935-988CBE31-A9D4-4390-8A7F-7D63CF58D091Q36453486-458CE2C3-C1C6-4E7D-9DF9-17E16F761F4EQ36481665-136F9572-552A-4C43-8E2D-72991CC52AC0Q36511661-A0933499-A917-453A-BD46-A40A5049C308Q36528263-8636EC2D-CCDF-41DB-A1AB-064DBC6A15E3Q36580581-F4BE651A-73CF-4B7F-9B3C-4B5F3534371DQ36708951-D094305B-E5F5-426A-A2EF-AE424872EBDEQ36792570-4FFB77B7-8349-49DE-8BC2-4FFCCDE8606DQ37189885-685A35B8-81CE-4DFE-96CC-633446F47168Q37264547-02607C38-7FBD-45BF-A372-88A6E7F0CC54Q37389482-86D06E16-E5AE-4402-A753-889C7BB3AFBDQ37848476-55F3E011-793D-42B1-8053-2662B6BEE543Q37986616-04E35143-3E51-454F-9783-7E4A183D4E45
P2860
Effectiveness of nicotine patches in relation to genotype in women versus men: randomised controlled trial.
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Effectiveness of nicotine patc ...... : randomised controlled trial.
@ast
Effectiveness of nicotine patc ...... : randomised controlled trial.
@en
type
label
Effectiveness of nicotine patc ...... : randomised controlled trial.
@ast
Effectiveness of nicotine patc ...... : randomised controlled trial.
@en
prefLabel
Effectiveness of nicotine patc ...... : randomised controlled trial.
@ast
Effectiveness of nicotine patc ...... : randomised controlled trial.
@en
P2093
P2860
P1433
P1476
Effectiveness of nicotine patc ...... : randomised controlled trial.
@en
P2093
Elaine Johnstone
Michael Murphy
Patricia Yudkin
Sarah Roberts
Sarah Welch
Siân Griffiths
P2860
P304
P356
10.1136/BMJ.38050.674826.AE
P407
P577
2004-03-19T00:00:00Z